{
  "denotations": [
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 83,
        "end": 88
      }
    },
    {
      "id": "T5",
      "obj": "Disease",
      "span": {
        "begin": 188,
        "end": 191
      }
    },
    {
      "id": "T6",
      "obj": "Disease",
      "span": {
        "begin": 229,
        "end": 232
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 337,
        "end": 350
      }
    },
    {
      "id": "T8",
      "obj": "Chemical",
      "span": {
        "begin": 356,
        "end": 365
      }
    },
    {
      "id": "T9",
      "obj": "Disease",
      "span": {
        "begin": 166,
        "end": 185
      }
    },
    {
      "id": "T10",
      "obj": "Chemical",
      "span": {
        "begin": 337,
        "end": 365
      }
    },
    {
      "id": "T11",
      "obj": "Chemical",
      "span": {
        "begin": 153,
        "end": 185
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "25687192_2",
  "text": "UNASSIGNED : Although the single-nucleotide polymorphism ( SNP ) rs12979860 in the IL28B gene is a better predictor of sustained virological response to treatment of chronic hepatitis C ( CHC ) than other baseline factors , some CHC patients with the favorable C allele can not achieve a sustained virological response when treated with peginterferon plus ribavirin ."
}
